Akkhasutthikun P, Kaewsapsak P, Nimsamer P, Klomkliew P, Visedthorn S, Chanchaem P, Teerapakpinyo C, Payungporn S, Luangdilok S (2024) Tissue and plasma-based highly sensitive blocker displacement amplicon nanopore sequencing for EGFR mutations in lung cancer. Cancer Res Treat 56(2):455–463. https://doi.org/10.4143/crt.2023.1108

Article  CAS  PubMed  Google Scholar 

Atser MG, Wenyonu CD, Rowe EM, Leung CLK, Cen HH, Queathem ED, Liu LT, Moravcova R, Rogalski J, Perrin D, Crawford P, Foster LJ, Alcazar A, Johnson JD (2025) Pyruvate dehydrogenase kinase 1 controls triacylglycerol hydrolysis in cardiomyocytes. J Biol Chem 301(4):108398. https://doi.org/10.1016/j.jbc.2025.108398

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bao R, Christova T, Song S, Angers S, Yan X, Attisano L (2012) Inhibition of tankyrases induces Axin stabilization and blocks Wnt signalling in breast cancer cells. PLoS ONE 7(11):e48670. https://doi.org/10.1371/journal.pone.0048670

Article  CAS  PubMed  PubMed Central  Google Scholar 

Binder ZA, Thorne AH, Bakas S, Wileyto EP, Bilello M, Akbari H, Rathore S, Ha SM, Zhang L, Ferguson CJ, Dahiya S, Bi WL, Reardon DA, Idbaih A, Felsberg J, Hentschel B, Weller M, Bagley SJ, Morrissette JJD, Nasrallah MP, Ma J, Zanca C, Scott AM, Orellana L, Davatzikos C, Furnari FB, O’Rourke DM (2018) Epidermal growth factor receptor extracellular domain mutations in glioblastoma present opportunities for clinical imaging and therapeutic development. Cancer Cell 34(1):163-177.e7. https://doi.org/10.1016/j.ccell.2018.06.006

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bleeker FE, Molenaar RJ, Leenstra S (2012) Recent advances in the molecular understanding of glioblastoma. J Neurooncol 108(1):11–27. https://doi.org/10.1007/s11060-011-0793-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang Y, Yang J, Li Z, Zhu X, Jiang T, Wang Q, Yu M, Han B, Liu X (2025) Epigenetically elevated RAD51AP1 regulates the RAD51-UAF1 complex contributing to temozolomide resistance in EGFRvIII glioblastoma. Chin Med J (Engl). https://doi.org/10.1097/CM9.0000000000003567

Chen S, Yang L, Li Z, Zhuo S, Yan B, Zhang Z, Zhang J, Feng H, Yang K (2021) EGFR/EGFRvIII partly regulates the tumourigenesis of glioblastoma through the SOX9-GLUT3 axis. Am J Transl Res 13(6):6055–6065

CAS  PubMed  PubMed Central  Google Scholar 

Daina A, Zoete V (2016) A boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem 11(11):1117–1121. https://doi.org/10.1002/cmdc.201600182

Article  CAS  PubMed  PubMed Central  Google Scholar 

Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https://doi.org/10.1038/srep42717

Article  PubMed  PubMed Central  Google Scholar 

Gibadulinova A, Bullova P, Strnad H, Pohlodek K, Jurkovicova D, Takacova M, Pastorekova S, Svastova E (2020) CAIX-mediated control of LIN28/let-7 axis contributes to metabolic adaptation of breast cancer cells to hypoxia. Int J Mol Sci 21(12):4299. https://doi.org/10.3390/ijms21124299

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gilbert MR, Wang M, Aldape KD, Stupp R, Hegi ME, Jaeckle KA, Armstrong TS, Wefel JS, Won M, Blumenthal DT, Mahajan A, Schultz CJ, Erridge S, Baumert B, Hopkins KI, Tzuk-Shina T, Brown PD, Chakravarti A, Curran WJ Jr, Mehta MP (2013) Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. J Clin Oncol 31(32):4085–4091. https://doi.org/10.1200/JCO.2013.49.6968

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo RM, Zhao CB, Li P, Zhang L, Zang SH, Yang B (2018) Overexpression of CLEC18B associates with the proliferation, migration, and prognosis of glioblastoma. ASN Neuro 10:1759091418781949. https://doi.org/10.1177/1759091418781949

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo G, Gong K, Beckley N, Zhang Y, Yang X, Chkheidze R, Hatanpaa KJ, Garzon-Muvdi T, Koduru P, Nayab A, Jenks J, Sathe AA, Liu Y, Xing C, Wu SY, Chiang CM, Mukherjee B, Burma S, Wohlfeld B, Patel T, Mickey B, Abdullah K, Youssef M, Pan E, Gerber DE, Tian S, Sarkaria JN, McBrayer SK, Zhao D, Habib AA (2022) EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulation. Nat Cell Biol 24(8):1291–1305. https://doi.org/10.1038/s41556-022-00962-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu K, Wang ZM, Li JN, Zhang S, Xiao ZF, Tao YM (2018) CLEC1B expression and PD-L1 expression predict clinical outcome in hepatocellular carcinoma with tumor hemorrhage. Transl Oncol 11(2):552–558. https://doi.org/10.1016/j.tranon.2018.02.010

Article  PubMed  PubMed Central  Google Scholar 

Hu C, Leche CA 2nd, Kiyatkin A, Yu Z, Stayrook SE, Ferguson KM, Lemmon MA (2022) Glioblastoma mutations alter EGFR dimer structure to prevent ligand bias. Nature 602(7897):518–522. https://doi.org/10.1038/s41586-021-04393-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ianevski A, Giri AK, Aittokallio T (2022) SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples. Nucleic Acids Res 50(W1):W739–W743. https://doi.org/10.1093/nar/gkac382

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lamborn KR, Yung WK, Chang SM, Wen PY, Cloughesy TF, DeAngelis LM, Robins HI, Lieberman FS, Fine HA, Fink KL, Junck L, Abrey L, Gilbert MR, Mehta M, Kuhn JG, Aldape KD, Hibberts J, Peterson PM, Prados MD, North American Brain Tumor Consortium (2008) Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas. Neuro Oncol 10(2):162–170. https://doi.org/10.1215/15228517-2007-062

Article  PubMed  PubMed Central  Google Scholar 

Li C, Zheng X, Han Y, Lv Y, Lan F, Zhao J (2018) XAV939 inhibits the proliferation and migration of lung adenocarcinoma A549 cells through the WNT pathway. Oncol Lett 15(6):8973–8982. https://doi.org/10.3892/ol.2018.8491

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin B, Ziebro J, Smithberger E, Skinner KR, Zhao E, Cloughesy TF, Binder ZA, O’Rourke DM, Nathanson DA, Furnari FB, Miller CR (2023) Corrigendum to: EGFR, the Lazarus target for precision oncology in glioblastoma. Neuro Oncol 25(1):213. https://doi.org/10.1093/neuonc/noac254

Article  CAS  PubMed  Google Scholar 

Lin Z, Gu Y, Liu Y, Chen Z, Fang S, Wang Z, Liu Z, Lin Q, Hu Y, Jiang N, Yu B, Liu G (2025) Melatonin attenuates inflammatory bone loss by alleviating mitophagy and lactate production. Apoptosis. https://doi.org/10.1007/s10495-025-02096-y

Article  PubMed  Google Scholar 

Liu CJ, Hu FF, Xie GY, Miao YR, Li XW, Zeng Y, Guo AY (2023) GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform 24(1):bbac558. https://doi.org/10.1093/bib/bbac558

Article  CAS  PubMed  Google Scholar 

Luger AL, Lorenz NI, Urban H, Divé I, Engel AL, Strassheimer F, Dettmer K, Zeiner PS, Shaid S, Struve N, Kriegs M, Hofmann U, Oefner PJ, Harter PN, Steinbach JP, Ronellenfitsch MW (2020) Activation of epidermal growth factor receptor sensitizes glioblastoma cells to hypoxia-induced cell death. Cancers (Basel) 12(8):2144. https://doi.org/10.3390/cancers12082144

Article  CAS  PubMed  Google Scholar 

Noeuveglise A, Sarafan-Vasseur N, Beaussire L, Marguet F, Modzelewski R, Hanzen C, Alexandru C, Magne N, Langlois O, Di Fiore F, Clatot F, Thureau S, Fontanilles M (2023) Impact of EGFRA289T/V mutation on relapse pattern in glioblastoma. ESMO Open 8(1):100740. https://doi.org/10.1016/j.esmoop.2022.100740

Article  CAS  PubMed  Google Scholar 

Pellerino A, Brastianos PK, Rudà R, Soffietti R (2021) Leptomeningeal metastases from solid tumors: recent advances in diagnosis and molecular approaches. Cancers (Basel) 13(12):2888. https://doi.org/10.3390/cancers13122888

Article  CAS  PubMed  Google Scholar 

Qin A, Musket A, Musich PR, Schweitzer JB, Xie Q (2021) Receptor tyrosine kinases as druggable targets in glioblastoma: do signaling pathways matter? Neurooncol Adv 3(1):vdab133. https://doi.org/10.1093/noajnl/vdab133

Article  PubMed  PubMed Central  Google Scholar